• Patient Action Center
  • Seniors Rising Now
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • 117th Congress Advocacy Scorecard
    • Legislative Positions
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
    • Patient Action Center
    • What You Can Do
    • Advocacy Masterclass
  • Donate

Tag: FDA

Terry Wilcox Statement on CMS’ Coverage Determination for Alzheimer’s

Terry Wilcox Statement on CMS’ Coverage Determination for Alzheimer’s

Apr 9, 2022 | Access, Featured

WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
FDA Must Step Up Oversight of Hand Sanitizer Safety

FDA Must Step Up Oversight of Hand Sanitizer Safety

Jul 22, 2021 | Federal Issues

FDA Must Step Up Oversight of Hand Sanitizer Safety By Marlene Wüst Smith, MD Hand sanitizer – it’s the go-to item for protecting our kids, even our “big” kids, those attending college in person. We keep it in our cars, our briefcases, kids’ backpacks, and our...
Read more
Season 2 | Episode 25: Crash Course: FDA Advisory Committees

Season 2 | Episode 25: Crash Course: FDA Advisory Committees

Jun 27, 2021 | Featured, Federal Issues, Podcast

On this episode of the podcast, Terry and Bob discuss the FDA’s advisory committees, which help the agency decide how to make its approval decisions. Three committee members recently resigned following the FDA’s approval of Aduhelm, the first new...
Read more
Season 2 | Episode 25: Crash Course: FDA Advisory Committees

S2:EP16 | Inside the FDA with Dr. Woodcock

Apr 26, 2021 | COVID-19, Featured, Federal Issues

On this episode of the podcast, Terry and Bob discuss the Food and Drug Administration and its lessons learned from the pandemic. They highlight how best practices from Operation Warp Speed and research on Covid-19 long haulers can inform ongoing treatments for those...
Read more

Categories

  • Access
  • Advocacy
  • California
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Rural Hospital Closures Further Complicates Healthcare Access in Mississippi
  • Contract Changes Leave DoD TRICARE Beneficiaries Without Pharmacy Access
  • Most Popular Podcast Episodes in 2022 From Patients Rising
  • Patients Rising Now Signs onto Letter to President on Alzheimer’s Scans
  • PRN and 17 Patient Groups Send Letter to Hill on Home Health Cuts

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Patient Action Center
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2023 Patients Rising Now